Who Paid My Doc
Annie Rodriguez
Optometrist, Occupational Vision Miami, FL Doctor of Optometry
NPI 1346261047 CMS profile 942393
7352 Nw 34Th St, Miami, FL 33122
General payments
$56
Research payments
$0
Ownership & investment interest
$0
Through program year 2019, Annie Rodriguez of Miami, FL is reported in the CMS Open Payments database as having received $56 across 1 general payment and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2019 | General | $56 | 1 |
Beside peers
- Annie Rodriguez
- Optometrist, Occupational Vision median
- Middle half of Optometrist, Occupational Vision
- National median
In program year 2025, general payments to Annie Rodriguez were reported at $0. Among 36 Optometrist, Occupational Vision profiles paid that year, the median was $169 and the middle half received between $74 and $354.
Show as a table
| Year | Annie Rodriguez | Optometrist, Occupational Vision median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $56 | $111 | $43–$215 | $163 |
| 2020 | $0 | $67 | $34–$141 | $114 |
| 2021 | $0 | $105 | $25–$202 | $132 |
| 2022 | $0 | $100 | $43–$178 | $149 |
| 2023 | $0 | $177 | $107–$325 | $160 |
| 2024 | $0 | $187 | $99–$278 | $164 |
| 2025 | $0 | $169 | $74–$354 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 8 drugsPart D claims
273
Drug cost
$22,833
Branded share of claims
31.1%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Restasis Cyclosporine | Brand | 26 | $17,763 | |
| Azelastine Hcl | Generic | 39 | $1,270 | |
| Prednisolone Acetate | Generic | 33 | $1,194 | |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | Brand | 15 | $880 | |
| Erythromycin Erythromycin Base | Brand | 44 | $613 | |
| Ofloxacin | Generic | 44 | $604 | |
| Latanoprost | Generic | 58 | $425 | |
| Brimonidine Tartrate | Generic | 14 | $84 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 27,653 Part D prescribers listed as Optometry; they describe a distribution and say nothing about conduct.
Records
1 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Optometrist, Occupational Vision in Florida
Tanja Moennichmeyer
Optometrist, Occupational Vision · Miami, FL
Daniel McIntosh
Optometrist, Occupational Vision · Jacksonville, FL
Gregory Laskerr
Optometrist, Occupational Vision · Tampa, FL
Jodi Stern
Optometrist, Occupational Vision · Miami, FL
William Kahn
Optometrist, Occupational Vision · Miami, FL
Michelle Trotman
Optometrist, Occupational Vision · Miami, FL
Related records
Optometrist, Occupational Vision in Florida
Practitioners in the same specialty and state, ranked by reported value.
All Optometrist, Occupational Vision
Everyone recorded under this specialty, nationwide.
Doctors in Florida
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.